
Boehringer Ingelheim and Tessellate Bio to Develop Treatments for People with Hard-to-Treat Cancers
Boehringer Ingelheim and Tessellate Bio have entered into a research collaboration and global license agreement. Jointly the partners will focus on the development of first-in-class, oral precision treatments for people living with cancer. Cancer continues …